Page last updated: 2024-08-18

pyrazolanthrone and Cancer of Larynx

pyrazolanthrone has been researched along with Cancer of Larynx in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, B; Chou, KY; Li, Q; Liu, F; Lu, LM; Tao, L; Zhang, D; Zhou, J; Zhou, L1
Abid, K; Aroui, S; Brahim, S; Kenani, A1

Other Studies

2 other study(ies) available for pyrazolanthrone and Cancer of Larynx

ArticleYear
Low concentrations of trichosanthin induce apoptosis and cell cycle arrest via c-Jun N-terminal protein kinase/mitogen-activated protein kinase activation.
    Molecular medicine reports, 2015, Volume: 11, Issue:1

    Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Laryngeal Neoplasms; Protein Kinase Inhibitors; Trichosanthin

2015
Involvement of C-jun NH2-terminal kinase and apoptosis induced factor in apoptosis induced by deglycosylated bleomycin in laryngeal carcinoma cells.
    Cell biology international, 2009, Volume: 33, Issue:9

    Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Inducing Factor; Bleomycin; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Fas Ligand Protein; Humans; JNK Mitogen-Activated Protein Kinases; Laryngeal Neoplasms; Leukemia; Mitochondria; TNF-Related Apoptosis-Inducing Ligand

2009